Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03401814 · ClinicalTrials.gov registry record
Imaging Response to Immunotherapy and Radiation Therapy in Patients With Liver Metastases
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 1
- Enrollment target
NCT03401814: Completed study, sponsored by Mayo Clinic.
NCT03401814 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03401814 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 1 participants
- Enrollment target
Study Summary
Patients will be imaged with MRE at the time of the RT planning MRI, prior to the induction of RT and immunotherapy. Research imaging will be in addition to standard imaging studies performed at time points consistent with the standard of care (at the time of the RT planning MRI and the first clinical follow-up). An additional MRE exam will be performed at the end of treatment outside the standard of care imaging.
Interventions
- OTHER Magnetic Resonance Elastography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2018-08-02 |
| Est. Completion | 2019-12-12 |
What the finished NCT03401814 record still lists
NCT03401814 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 1 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Magnetic Resonance Elastography is the first listed.
NCT03401814 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03401814 about?
NCT03401814 is a clinical study titled "Imaging Response to Immunotherapy and Radiation Therapy in Patients With Liver Metastases". Patients will be imaged with MRE at the time of the RT planning MRI, prior to the induction of RT and immunotherapy. Research imaging will be in addition to standard imaging studies performed at time points consistent with the standard of care (at the time of the RT planning MRI and the first clinic...
What is the current status of trial NCT03401814?
This trial is currently completed. The enrollment target is 1 participants. The study started on 2018-08-02. Estimated completion is 2019-12-12.
What interventions are being tested in trial NCT03401814?
The interventions under investigation include: Magnetic Resonance Elastography (OTHER).
Who is sponsoring clinical trial NCT03401814?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI